According to Anixa Biosciences's latest financial reports the company's total liabilities are $1.76 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-10-31 | $2.15 M | -2.76% |
2022-10-31 | $2.21 M | 48.46% |
2021-10-31 | $1.49 M | 25.36% |
2020-10-31 | $1.18 M | -19.76% |
2019-10-31 | $1.48 M | 17.09% |
2018-10-31 | $1.26 M | 42.23% |
2017-10-31 | $0.88 M | -80.83% |
2016-10-31 | $4.64 M | 8.38% |
2015-10-31 | $4.28 M | -15.14% |
2014-10-31 | $5.04 M | -42.4% |
2013-10-31 | $8.76 M | 27.8% |
2012-10-31 | $6.85 M | -9.66% |
2011-10-31 | $7.58 M | 39.22% |
2010-10-31 | $5.45 M | 1% |
2009-10-31 | $5.39 M | -6.44% |
2008-10-31 | $5.76 M | 749.66% |
2007-10-31 | $0.67 M | 16.68% |
2006-10-31 | $0.58 M | 67.07% |
2005-10-31 | $0.34 M | -21.41% |
2004-10-31 | $0.44 M | 29.46% |
2003-10-31 | $0.34 M | -17.33% |
2002-10-31 | $0.41 M | -82.72% |
2001-10-31 | $2.39 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $27.91 M | 1,479.13% | ๐บ๐ธ USA |